Distinguished in Transient Ischemic Attack (TIA)

Ken S. Butcher

Randwick, NSW, AU 
Distinguished in Transient Ischemic Attack (TIA)
Randwick, NSW, AU 
OverviewLocationsClinical Research

Overview

Ken Butcher practices in Randwick, Australia. Butcher is rated as a Distinguished expert by MediFind in the treatment of Transient Ischemic Attack (TIA). Their top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Atrial Fibrillation, Thrombectomy, and Endovascular Embolization.

Their clinical research consists of co-authoring 78 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles and participated in 3 clinical trials in the study of Transient Ischemic Attack (TIA).

Locations

Randwick, NSW 2031, Australia
Other Locations
Ingham, QLD, Australia
Sydney, NSW, Australia
Kensington, NSW, Australia
Liverpool, NSW, Australia
NSW, Australia
Melbourne, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Enrollment Status: Suspended
Publish Date: June 05, 2025
Intervention Type: Drug
Study Phase: Phase 2
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Enrollment Status: Terminated
Publish Date: November 06, 2024
Intervention Type: Drug
Study Drug: Labetalol+Hydralazine+Enalapril
Study Phase: Phase 2
Lixiana Acute Stroke Evaluation Registry
Lixiana Acute Stroke Evaluation Registry
Enrollment Status: Completed
Publish Date: April 05, 2024
Intervention Type: Drug
Study Drug: Edoxaban
Study Phase: Phase 4
Canadian Pradaxa Acute Stroke Safety Study
Canadian Pradaxa Acute Stroke Safety Study
Enrollment Status: Completed
Publish Date: June 19, 2020
Intervention Type: Drug
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Enrollment Status: Completed
Publish Date: March 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Dabigatran Following Transient Ischemic Attack and Minor Stroke
Enrollment Status: Completed
Publish Date: January 30, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

78 Total Publications

Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial.
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial.
Journal: Stroke
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Butcher's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile